Figure 2.
Low expression of miR-369 predicts the poor prognosis of HCC patients. A. Real-time PCR analysis of miR-369 in HCCs and peri-tumor normal tissues from 120 patients (p<0.05). B & C. Real-time PCR and scoring of miR-369 expression were performed in 120 human HCC samples. Overall survival time and disease-free survival after surgery of the patients were compared between the ''miR-369 low'' (n = 60) and ''miR-369 high'' (n = 60) groups, p <0.05.
